Stock 9776 SAPPORO CLINICAL LABORATORY INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Sapporo Clinical Laboratory Inc.

Equities

9776

JP3321100004

Drug Retailers

Delayed Japan Exchange
Other stock markets
 08:37:18 2024-04-29 pm EDT 		5-day change 1st Jan Change
1,078 JPY -0.19% Intraday chart for Sapporo Clinical Laboratory Inc. -0.55% +7.69%
Mar. 27 Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on February 26, 2024. CI
Mar. 26 Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on March 26, 2024, has closed with 210,800 shares, representing 6.33% for ¥189.93 million. CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 7,791 6,744 5,470 5,244 4,346 4,220
Enterprise Value (EV) 1 3,774 2,305 2,832 4,986 3,937 2,983
P/E ratio 11.4 x 12.9 x 10.4 x 6.61 x 4.24 x 7.44 x
Yield 0.49% 0.51% 0.63% 1.5% 1.77% 1.82%
Capitalization / Revenue 0.45 x 0.4 x 0.31 x 0.3 x 0.23 x 0.21 x
EV / Revenue 0.22 x 0.14 x 0.16 x 0.28 x 0.21 x 0.15 x
EV / EBITDA 2.77 x 2.05 x 2.38 x 3.53 x 1.89 x 1.95 x
EV / FCF 3.91 x 5.52 x -1.65 x -2.13 x -101 x 3.43 x
FCF Yield 25.6% 18.1% -60.4% -47% -0.99% 29.1%
Price to Book 1.03 x 0.85 x 0.65 x 0.57 x 0.43 x 0.4 x
Nbr of stocks (in thousands) 3,463 3,423 3,423 3,423 3,353 3,331
Reference price 2 2,250 1,970 1,598 1,532 1,296 1,267
Announcement Date 6/26/18 6/25/19 6/25/20 6/25/21 6/29/22 6/29/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 17,459 17,065 17,659 17,502 19,109 20,127
EBITDA 1 1,362 1,123 1,190 1,413 2,084 1,532
EBIT 1 1,020 815 946 1,142 1,537 1,013
Operating Margin 5.84% 4.78% 5.36% 6.52% 8.04% 5.03%
Earnings before Tax (EBT) 1 1,051 817 845 1,175 1,500 958
Net income 1 685 523 528 793 1,042 568
Net margin 3.92% 3.06% 2.99% 4.53% 5.45% 2.82%
EPS 2 197.0 152.3 154.3 231.7 305.9 170.4
Free Cash Flow 1 965.9 417.8 -1,712 -2,344 -39 869.1
FCF margin 5.53% 2.45% -9.69% -13.39% -0.2% 4.32%
FCF Conversion (EBITDA) 70.92% 37.2% - - - 56.73%
FCF Conversion (Net income) 141% 79.88% - - - 153.01%
Dividend per Share 2 11.00 10.00 10.00 23.00 23.00 23.00
Announcement Date 6/26/18 6/25/19 6/25/20 6/25/21 6/29/22 6/29/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2020 S1 2021 S1 2022 S1 2022 Q3 2023 Q1 2023 S1 2023 Q3 2024 Q1 2024 S1 2024 Q3
Net sales 1 8,838 8,364 9,566 4,719 4,900 9,964 5,286 4,922 9,862 4,990
EBITDA - - - - - - - - - -
EBIT 1 492 368 777 309 131 492 324 75 291 123
Operating Margin 5.57% 4.4% 8.12% 6.55% 2.67% 4.94% 6.13% 1.52% 2.95% 2.46%
Earnings before Tax (EBT) 1 490 365 717 307 222 508 382 74 386 122
Net income 1 326 225 457 204 78 258 235 5 226 85
Net margin 3.69% 2.69% 4.78% 4.32% 1.59% 2.59% 4.45% 0.1% 2.29% 1.7%
EPS 2 95.25 65.88 134.1 59.83 23.35 77.37 70.48 1.720 67.94 25.73
Dividend per Share - - - - - - - - - -
Announcement Date 11/11/19 11/9/20 11/8/21 2/9/22 8/8/22 11/9/22 2/10/23 8/7/23 11/10/23 2/9/24
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 4,017 4,439 2,638 258 409 1,237
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 966 418 -1,712 -2,344 -39 869
ROE (net income / shareholders' equity) 9.4% 6.72% 6.42% 8.94% 10.7% 6.02%
ROA (Net income/ Total Assets) 6.28% 4.79% 5.32% 5.48% 6.27% 3.88%
Assets 1 10,916 10,919 9,926 14,479 16,629 14,655
Book Value Per Share 2 2,194 2,331 2,472 2,708 3,016 3,178
Cash Flow per Share 2 1,171 1,308 797.0 689.0 892.0 1,100
Capex 1 299 243 2,974 3,142 837 811
Capex / Sales 1.71% 1.42% 16.84% 17.95% 4.38% 4.03%
Announcement Date 6/26/18 6/25/19 6/25/20 6/25/21 6/29/22 6/29/23
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly earnings - Rate of surprise

Company calendar

Sector Retail - Drugs without Grocery

1st Jan change Capi.
SAPPORO CLINICAL LABORATORY INC. Stock Sapporo Clinical Laboratory Inc.
+7.69% 22.85M
RAIA DROGASIL S.A. Stock Raia Drogasil S.A.
-12.48% 8.57B
AIN HOLDINGS INC. Stock Ain Holdings Inc.
+34.58% 1.32B
QOL HOLDINGS CO., LTD. Stock Qol Holdings Co., Ltd.
+6.70% 419M
NIHON CHOUZAI CO.,LTD. Stock NIHON CHOUZAI Co.,Ltd.
+8.15% 282M
SALUS, LJUBLJANA, D. D. Stock SALUS, Ljubljana, d. d.
+10.56% 224M
GREEN CROSS HEALTH LIMITED Stock Green Cross Health Limited
-8.26% 85.07M
MEDICAL IKKOU GROUP CO.,LTD. Stock Medical Ikkou Group Co.,Ltd.
+21.18% 59.57M
Retail - Drugs without Grocery
  1. Stock Market
  2. Equities
  3. 9776 Stock
  4. Financials Sapporo Clinical Laboratory Inc.